No profile data available.
Veradermics, Incorporated (MANE) is a listed company, based in New Haven, United States, with about 37 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$83.37 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $5.47 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.
Veradermics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$5.47 billion as of October 9, 2026.